Population Health Science and Policy

Search results

• Yellow Off-Road Lights Work. Here’s Why

  John Bullough

  19/12/22

  2 items of Media coverage

  Press/Media

• Weekly: Mesoblast (MSB: 95.0c) increases 0.5% on below average volume; +0.5c [0.5%]

  Eric Rose

  19/12/22

  1 item of Media coverage

  Press/Media

• Disparities in prenatal care linked to citizenship status and education level

  Ashley Fox & Teresa Janevic

  19/12/22

  1 item of Media coverage

  Press/Media

• Stand up and judge your crown: How the hashtag #ShareYourRejection encourages

  Guy Montgomery

  17/12/22

  1 item of Media coverage

  Press/Media

• Researchers from Icahn School of Medicine at Mount Sinai Discuss Findings in Insurance (Growth of Fee-for-service Medicare Home-based Medical Care Within Private Residences and Domiciliary Care Settings In the Us, 2012-2019)

  Bian Liu, Katherine Ornstein, Claire Ankuda & Jennifer Reckrey

  16/12/22

  1 item of Media coverage

  Press/Media

• Mesoblast (MSB: 94.0c) decreases 2.6% weakening below moving average price

  Eric Rose

  15/12/22

  1 item of Media coverage

  Press/Media

• Icahn School of Medicine at Mount Sinai Researcher Publishes New Study Findings on Cardiac Surgery (Sex Disparities in Failure to Rescue After Cardiac Surgery in California and New York)

  Natalia Egorova & Joanna Chikwe,

  15/12/22

  1 item of Media coverage

  Press/Media

• Mesoblast (MSB: 94.0c) - PRE-MARKET CONFIRMATORY BEARISH SIGNAL FROM ITS ADR MARKET Friday December 16, 2022 08:12 AEDT

  Eric Rose

  15/12/22

  1 item of Media coverage

  Press/Media

• University of Miami Miller School of Medicine Researchers Detail Research in Prostate Cancer (Cone-beam CT delta-radiomics to predict genitourinary toxicities and international prostate symptom of prostate cancer patients: a pilot study)

  Deukwoo Kwon

  14/12/22

  1 item of Media coverage

  Press/Media

• Mesoblast (MSB: 96.50c) drops 2.0% on increasing volatility

  Eric Rose

  14/12/22

  1 item of Media coverage

  Press/Media

• Researchers at Icahn School of Medicine at Mount Sinai Report New Data on Salvage Therapy (Temporary Mechanical Circulatory Support Devices: Practical Considerations for All Stakeholders)

  Anuradha Lala-Trindade,, Noah Moss, Benjamin Salter, & Anelechi Anyanwu,

  14/12/22

  1 item of Media coverage

  Press/Media

• Mesoblast (MSB: 94.50c) - PRE-MARKET CONFIRMATORY BEARISH SIGNAL FROM ITS ADR MARKET Monday December 12, 2022 08:12 AEDT

  Eric Rose

  9/12/22 → 13/12/22

  2 items of Media coverage

  Press/Media

• Mesoblast (MSB: 95.0c) increases

  Eric Rose

  12/12/22 → 13/12/22

  3 items of Media coverage

  Press/Media

• Disparities in access to prenatal care based on citizenship status and education level

  Ashley Fox & Teresa Janevic

  13/12/22

  1 item of Media coverage

  Press/Media

• Shenzhen Campus of Sun Yat-sen University Reports Findings in Mesenchymal Stem Cells (Combination therapy of hydrogel and stem cells for diabetic wound healing)

  Yan Li

  9/12/22

  1 item of Media coverage

  Press/Media

• Mesoblast (MSB: 96.0c) keeps sliding, down 16% in 3 days

  Eric Rose

  8/12/22

  1 item of Media coverage

  Press/Media

• Study Results from Icahn School of Medicine at Mount Sinai Broaden Understanding of Veterans (Prophylactic Feeding Tube Placement for Squamous Cell Carcinoma of the Head and Neck)

  Deborah Marshall, Keith Sigel, Deborah Marshall, Rocco Ferrandino, Richard Bakst & Scott Roof

  8/12/22

  1 item of Media coverage

  Press/Media

• Research from Shanghai Jiao Tong University School of Medicine in the Area of Adenocarcinoma Published (Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma)

  Yan Li

  8/12/22

  1 item of Media coverage

  Press/Media

• Studies from Shanghai Jiao Tong University Add New Findings in the Area of Kidney Cancer (Impact of interaction networks of B cells with other cells on tumorigenesis, progression and response to immunotherapy of renal cell carcinoma: A review)

  Yan Li

  7/12/22

  1 item of Media coverage

  Press/Media

• Mesoblast (MSB: 98.50c) - PRE-MARKET CONFIRMATORY BEARISH SIGNAL FROM ITS ADR MARKET Thursday December 08, 2022 08:12 AEDT

  Eric Rose

  7/12/22

  1 item of Media coverage

  Press/Media

• Mesoblast (MSB: 98.50c) sinks 4.8% weakening below moving average price

  Eric Rose

  7/12/22

  1 item of Media coverage

  Press/Media

• Mesoblast (MSB: $A1.03) slides 9.6% weakening below moving average price

  Eric Rose

  6/12/22

  1 item of Media coverage

  Press/Media

• Melbourne international comedy festival is back with 2023 lineup

  Guy Montgomery

  6/12/22

  1 item of Media coverage

  Press/Media

• Shanghai Jiao Tong University School of Medicine Reports Findings in Antihypertensives (Seasonal variation in the effect of antihypertensive treatment with the irbesartan/hydrochlorothiazide combination)

  Yan Li

  6/12/22

  1 item of Media coverage

  Press/Media

• Tisch Cancer Institute Researchers Describe New Findings in Non-Small Cell Lung Cancer (Real-World longitudinal practice patterns in the use of PD-1 and PD-L1 inhibitors as First-Line therapy in patients with Non-Small cell lung cancer in the ...)

  Emanuela Taioli, Fred Hirsch, Fred Hirsch & Rajwanth Veluswamy

  6/12/22

  1 item of Media coverage

  Press/Media